MoneyWorks4Me

Guj. Inject (Kerala) - Quaterly Results

22 May 2023 Evaluate
Revenue showed a marginal decline at Rs. 0.00 millions. For the quarter ended March 2023, as compared to corresponding quarter of last year.A big loss of -81.82% reported for the quarter ended March 2023 to Rs. 0.06  millions from Rs. 0.33 millions.Operating profit for the quarter ended March 2023 decreased to 0.08 millions as compared to 0.34 millions of corresponding quarter ended March 2022.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202303 202203 % Var 202303 202203 % Var 202303 202203 % Var
Sales 0.00 0.00 0.00 1.74 0.23 656.52 1.74 0.23 656.52
Other Income 0.30 0.43 -30.23 4.33 0.48 802.08 4.33 0.48 802.08
PBIDT 0.08 0.34 -76.47 0.55 0.04 1275.00 0.55 0.04 1275.00
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBDT 0.08 0.34 -76.47 0.55 0.04 1275.00 0.55 0.04 1275.00
Depreciation 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBT 0.08 0.34 -76.47 0.55 0.04 1275.00 0.55 0.04 1275.00
TAX 0.02 0.01 100.00 0.14 0.01 1300.00 0.14 0.01 1300.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 0.06 0.33 -81.82 0.41 0.03 1266.67 0.41 0.03 1266.67
Equity 48.85 48.85 0.00 48.85 48.85 0.00 48.85 48.85 0.00
PBIDTM(%) 0.00 0.00 0.00 31.61 17.39 81.75 31.61 17.39 81.75
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..